BR0100827A - Fator estimulador de colÈnias de granulócitosestabilizado - Google Patents

Fator estimulador de colÈnias de granulócitosestabilizado

Info

Publication number
BR0100827A
BR0100827A BR0100827-7A BR0100827A BR0100827A BR 0100827 A BR0100827 A BR 0100827A BR 0100827 A BR0100827 A BR 0100827A BR 0100827 A BR0100827 A BR 0100827A
Authority
BR
Brazil
Prior art keywords
stimulating factor
colony stimulating
granulocyte colony
stabilized
salt
Prior art date
Application number
BR0100827-7A
Other languages
English (en)
Inventor
Josephine Nanette Hay
Kathleen Brimelow Williams
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0100827A publication Critical patent/BR0100827A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Abstract

Patente de Invenção: "FATOR ESTIMULADOR DE COLÈNIASDE GRA-NULóCITOS ESTABILIZADO". A invenção refere-se acomposições aquosas estáveis de fator estimulador de colónias degra-nulócitos que tem um pH na faixa de pH 5 a pH 8 ecompreende um sal compreendendo íons sulfato, e a usos dasmesmas.
BR0100827-7A 2000-02-29 2001-02-22 Fator estimulador de colÈnias de granulócitosestabilizado BR0100827A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18576900P 2000-02-29 2000-02-29

Publications (1)

Publication Number Publication Date
BR0100827A true BR0100827A (pt) 2001-11-27

Family

ID=22682387

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0100827-7A BR0100827A (pt) 2000-02-29 2001-02-22 Fator estimulador de colÈnias de granulócitosestabilizado

Country Status (11)

Country Link
US (1) US6497869B2 (pt)
EP (1) EP1129720B1 (pt)
JP (1) JP3544180B2 (pt)
AT (1) ATE269716T1 (pt)
BR (1) BR0100827A (pt)
CA (1) CA2337661A1 (pt)
DE (1) DE60103940T2 (pt)
DK (1) DK1129720T3 (pt)
ES (1) ES2220673T3 (pt)
PT (1) PT1129720E (pt)
TR (1) TR200401573T4 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
JP2005521640A (ja) * 2001-11-13 2005-07-21 ジェネンテック・インコーポレーテッド Ａｐｏ−２リガンド／ＴＲＡＩＬ製剤
US7220407B2 (en) 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
EP1682184B1 (en) * 2003-11-04 2013-10-16 LEK Pharmaceuticals d.d. Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
US20090047239A1 (en) * 2005-06-06 2009-02-19 Novo Nordisk A/S Stabilised IL-21 Compositions
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
JP2010536906A (ja) 2007-08-27 2010-12-02 バイオジェネリクス アーゲー Ｇ−ｃｓｆの液体製剤
DE102007040932A1 (de) 2007-08-27 2009-03-05 Biogenerix Ag Flüssigformulierung von G-CSF
PE20110426A1 (es) 2008-07-23 2011-07-01 Ambrx Inc Polipeptidos g-csf bovinos modificados
JP5769379B2 (ja) * 2010-03-17 2015-08-26 グンゼ株式会社 Ｄａｎｃｅタンパク質溶液
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
ITMI20120338A1 (it) * 2012-03-06 2013-09-07 Dr Andrea Bignotti Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
EP3365359A1 (en) * 2015-10-19 2018-08-29 Sandoz AG Method for producing a recombinant protein with reduced impurities

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
GB2193621A (en) 1986-07-29 1988-02-17 Jan Mazura Plant support line
NZ229098A (en) 1988-05-13 1992-10-28 Amgen Inc (bg-csf) bovine granulocyte colony stimulating factor, recombinant methods and pharmaceuticals
US5104651A (en) 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
WO1991005798A1 (en) 1989-10-10 1991-05-02 Amgen Inc. Compositions and methods for treating or preventing infections in canine and feline animals
GB9107846D0 (en) 1990-04-30 1991-05-29 Ici Plc Polypeptides
IE912365A1 (en) 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
DE4126983A1 (de) 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
FR2686900B1 (fr) 1992-01-31 1995-07-21 Rhone Poulenc Rorer Sa Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant.
FR2693907B1 (fr) 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
DE4242863A1 (de) 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
DE4242919A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
AU691514B2 (en) 1993-07-19 1998-05-21 Amgen, Inc. Stabilization of aerosolized proteins
US5874075A (en) 1993-10-06 1999-02-23 Amgen Inc. Stable protein: phospholipid compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
EP0988861B1 (en) * 1998-08-17 2004-03-03 Pfizer Products Inc. Stabilized protein compositions

Also Published As

Publication number Publication date
DK1129720T3 (da) 2004-09-27
ATE269716T1 (de) 2004-07-15
US20020002133A1 (en) 2002-01-03
ES2220673T3 (es) 2004-12-16
PT1129720E (pt) 2004-08-31
JP3544180B2 (ja) 2004-07-21
EP1129720B1 (en) 2004-06-23
CA2337661A1 (en) 2001-08-29
DE60103940D1 (de) 2004-07-29
JP2001278898A (ja) 2001-10-10
US6497869B2 (en) 2002-12-24
DE60103940T2 (de) 2005-07-28
TR200401573T4 (tr) 2004-08-23
EP1129720A3 (en) 2001-09-26
EP1129720A2 (en) 2001-09-05

Similar Documents

Publication Publication Date Title
BR0100827A (pt) Fator estimulador de colÈnias de granulócitosestabilizado
DE60219383D1 (de) Wässrige Beschichtungszusammensetzung
DE60123389D1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
TW200724159A (en) Stable emulsion composition
CA2336845A1 (en) Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
YU72002A (sh) Benzoilpirazoli i njihova primena u ulozi herbicida
EP1236398A4 (en) MICROBICIDAL COMPOSITIONS
MXPA03007514A (es) Composicion de acido hipocloroso y sus aplicaciones.
ATE267592T1 (de) Klare wässrige anästhesierende zusammensetzung
HRP20030154B1 (en) Preparation of risperidone
GB0015027D0 (en) Aqueous coating composition
DE60109353D1 (de) Wässrige metallische Beschichtungszusammensetzung
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
BR0115727A (pt) Formulações dermatológicas
DE60234592D1 (de) Wässrige zusammensetzung
DE60001302T2 (de) Wässrige Beschichtungszusammensetzung
ATE536886T1 (de) Stabilisierte feste zusammensetzungen von modifizierter faktor vii
CY1108791T1 (el) Φυτοενδυναμωτικο μεσον
DK1100329T3 (da) Vækstregulerende vandige sammensætninger
CA2406492A1 (en) All natural mineral treatment
DE60124839D1 (de) Wässrige Beschichtungszusammensetzung
ATE506989T1 (de) Harnstoffhaltige haarglättungszusammensetzung
AU2002359695A8 (en) Aqueous ifosfamide composition
BR0209455A (pt) Dentifrìcio
DE60131379D1 (de) Wässrige zusammensetzung aus polyamidoaminen und tensiden zur papierherstellung

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009.